Global Bevacizumab Biosimilar Market Research Report 2016

August 2016 | 122 pages | ID: G1F0983FC0BEN
QYResearch

Abstracts

Notes:

Production, means the output of Bevacizumab Biosimilar

Revenue, means the sales value of Bevacizumab Biosimilar

This report studies Bevacizumab Biosimilar in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Pfizer
• Allergan
• Alnylam Pharmaceuticals
• Amgen
• Angstrom Pharmaceuticals
• Acceleron Pharma
• Biocon
• Bionomics
• CASI Pharmaceuticals
• Celgene Corporation
• Enzon Pharmaceuticals
• Five Prime Therapeutics
• Fujifilm Kyowa Kirin Biologics
• Genentech
• Genexine
• Hetero Drugs
• ImClone Systems
• Intas Pharmaceuticals
• Kyowa Hakko Kirin
• Levolta Pharmaceuticals
• Mabtech
• Marsala Biotech
• Neumedicines
• Novartis
• Oncobiologics
• Onyx Pharmaceuticals

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Bevacizumab Biosimilar in these regions, from 2011 to 2021 (forecast), like

• North America
• Europe
• China
• Japan
• Southeast Asia
• India

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Bevacizumab Biosimilar in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

Global Bevacizumab Biosimilar Market Research Report 2016

1 BEVACIZUMAB BIOSIMILAR MARKET OVERVIEW

1.1 Product Overview and Scope of Bevacizumab Biosimilar
1.2 Bevacizumab Biosimilar Segment by Type
  1.2.1 Global Production Market Share of Bevacizumab Biosimilar by Type in 2015
  1.2.2 Type I
  1.2.3 Type II
  1.2.4 Type III
1.3 Bevacizumab Biosimilar Segment by Application
  1.3.1 Bevacizumab Biosimilar Consumption Market Share by Application in 2015
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Bevacizumab Biosimilar Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 Europe Status and Prospect (2011-2021)
  1.4.3 China Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 Southeast Asia Status and Prospect (2011-2021)
  1.4.6 India Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Bevacizumab Biosimilar (2011-2021)

2 GLOBAL BEVACIZUMAB BIOSIMILAR MARKET COMPETITION BY MANUFACTURERS

2.1 Global Bevacizumab Biosimilar Production and Share by Manufacturers (2015 and 2016)
2.2 Global Bevacizumab Biosimilar Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Bevacizumab Biosimilar Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Bevacizumab Biosimilar Manufacturing Base Distribution, Sales Area and Product Type
2.5 Bevacizumab Biosimilar Market Competitive Situation and Trends
  2.5.1 Bevacizumab Biosimilar Market Concentration Rate
  2.5.2 Bevacizumab Biosimilar Market Share of Top 3 and Top 5 Manufacturers
  2.5.3 Mergers & Acquisitions, Expansion

3 GLOBAL BEVACIZUMAB BIOSIMILAR PRODUCTION, REVENUE (VALUE) BY REGION (2011-2016)

3.1 Global Bevacizumab Biosimilar Production and Market Share by Region (2011-2016)
3.2 Global Bevacizumab Biosimilar Revenue (Value) and Market Share by Region (2011-2016)
3.3 Global Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.4 North America Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.5 Europe Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.6 China Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.7 Japan Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.8 Southeast Asia Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
3.9 India Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)

4 GLOBAL BEVACIZUMAB BIOSIMILAR SUPPLY (PRODUCTION), CONSUMPTION, EXPORT, IMPORT BY REGIONS (2011-2016)

4.1 Global Bevacizumab Biosimilar Consumption by Regions (2011-2016)
4.2 North America Bevacizumab Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
4.3 Europe Bevacizumab Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
4.4 China Bevacizumab Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
4.5 Japan Bevacizumab Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
4.6 Southeast Asia Bevacizumab Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)
4.7 India Bevacizumab Biosimilar Production, Consumption, Export, Import by Regions (2011-2016)

5 GLOBAL BEVACIZUMAB BIOSIMILAR PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

5.1 Global Bevacizumab Biosimilar Production and Market Share by Type (2011-2016)
5.2 Global Bevacizumab Biosimilar Revenue and Market Share by Type (2011-2016)
5.3 Global Bevacizumab Biosimilar Price by Type (2011-2016)
5.4 Global Bevacizumab Biosimilar Production Growth by Type (2011-2016)

6 GLOBAL BEVACIZUMAB BIOSIMILAR MARKET ANALYSIS BY APPLICATION

6.1 Global Bevacizumab Biosimilar Consumption and Market Share by Application (2011-2016)
6.2 Global Bevacizumab Biosimilar Consumption Growth Rate by Application (2011-2016)
6.3 Market Drivers and Opportunities
  6.3.1 Potential Applications
  6.3.2 Emerging Markets/Countries

7 GLOBAL BEVACIZUMAB BIOSIMILAR MANUFACTURERS PROFILES/ANALYSIS

7.1 Pfizer
  7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.1.2 Bevacizumab Biosimilar Product Type, Application and Specification
    7.1.2.1 Type I
    7.1.2.2 Type II
  7.1.3 Pfizer Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.1.4 Main Business/Business Overview
7.2 Allergan
  7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.2.2 Bevacizumab Biosimilar Product Type, Application and Specification
    7.2.2.1 Type I
    7.2.2.2 Type II
  7.2.3 Allergan Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.2.4 Main Business/Business Overview
7.3 Alnylam Pharmaceuticals
  7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.3.2 Bevacizumab Biosimilar Product Type, Application and Specification
    7.3.2.1 Type I
    7.3.2.2 Type II
  7.3.3 Alnylam Pharmaceuticals Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.3.4 Main Business/Business Overview
7.4 Amgen
  7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.4.2 Bevacizumab Biosimilar Product Type, Application and Specification
    7.4.2.1 Type I
    7.4.2.2 Type II
  7.4.3 Amgen Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.4.4 Main Business/Business Overview
7.5 Angstrom Pharmaceuticals
  7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.5.2 Bevacizumab Biosimilar Product Type, Application and Specification
    7.5.2.1 Type I
    7.5.2.2 Type II
  7.5.3 Angstrom Pharmaceuticals Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.5.4 Main Business/Business Overview
7.6 Acceleron Pharma
  7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.6.2 Bevacizumab Biosimilar Product Type, Application and Specification
    7.6.2.1 Type I
    7.6.2.2 Type II
  7.6.3 Acceleron Pharma Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.6.4 Main Business/Business Overview
7.7 Biocon
  7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.7.2 Bevacizumab Biosimilar Product Type, Application and Specification
    7.7.2.1 Type I
    7.7.2.2 Type II
  7.7.3 Biocon Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.7.4 Main Business/Business Overview
7.8 Bionomics
  7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.8.2 Bevacizumab Biosimilar Product Type, Application and Specification
    7.8.2.1 Type I
    7.8.2.2 Type II
  7.8.3 Bionomics Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.8.4 Main Business/Business Overview
7.9 CASI Pharmaceuticals
  7.9.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.9.2 Bevacizumab Biosimilar Product Type, Application and Specification
    7.9.2.1 Type I
    7.9.2.2 Type II
  7.9.3 CASI Pharmaceuticals Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.9.4 Main Business/Business Overview
7.10 Celgene Corporation
  7.10.1 Company Basic Information, Manufacturing Base and Its Competitors
  7.10.2 Bevacizumab Biosimilar Product Type, Application and Specification
    7.10.2.1 Type I
    7.10.2.2 Type II
  7.10.3 Celgene Corporation Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2015 and 2016)
  7.10.4 Main Business/Business Overview
7.11 Enzon Pharmaceuticals
7.12 Five Prime Therapeutics
7.13 Fujifilm Kyowa Kirin Biologics
7.14 Genentech
7.15 Genexine
7.16 Hetero Drugs
7.17 ImClone Systems
7.18 Intas Pharmaceuticals
7.19 Kyowa Hakko Kirin
7.20 Levolta Pharmaceuticals
7.21 Mabtech
7.22 Marsala Biotech
7.23 Neumedicines
7.24 Novartis
7.25 Oncobiologics
7.26 Onyx Pharmaceuticals

8 BEVACIZUMAB BIOSIMILAR MANUFACTURING COST ANALYSIS

8.1 Bevacizumab Biosimilar Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Bevacizumab Biosimilar

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Bevacizumab Biosimilar Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Bevacizumab Biosimilar Major Manufacturers in 2015
9.4 Downstream Buyers

10 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

10.1 Marketing Channel
  10.1.1 Direct Marketing
  10.1.2 Indirect Marketing
  10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
  10.2.1 Pricing Strategy
  10.2.2 Brand Strategy
  10.2.3 Target Client
10.3 Distributors/Traders List

11 MARKET EFFECT FACTORS ANALYSIS

11.1 Technology Progress/Risk
  11.1.1 Substitutes Threat
  11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change

12 GLOBAL BEVACIZUMAB BIOSIMILAR MARKET FORECAST (2016-2021)

12.1 Global Bevacizumab Biosimilar Production, Revenue Forecast (2016-2021)
12.2 Global Bevacizumab Biosimilar Production, Consumption Forecast by Regions (2016-2021)
12.3 Global Bevacizumab Biosimilar Production Forecast by Type (2016-2021)
12.4 Global Bevacizumab Biosimilar Consumption Forecast by Application (2016-2021)
12.5 Bevacizumab Biosimilar Price Forecast (2016-2021)

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
China Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Bevacizumab Biosimilar
Figure Global Production Market Share of Bevacizumab Biosimilar by Type in 2015
Figure Product Picture of Type I
Table Major Manufacturers of Type I
Figure Product Picture of Type II
Table Major Manufacturers of Type II
Figure Product Picture of Type III
Table Major Manufacturers of Type III
Table Bevacizumab Biosimilar Consumption Market Share by Application in 2015
Figure Application 1 Examples
Figure Application 2 Examples
Figure Application 3 Examples
Figure North America Bevacizumab Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure Europe Bevacizumab Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure China Bevacizumab Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure Japan Bevacizumab Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure Southeast Asia Bevacizumab Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure India Bevacizumab Biosimilar Revenue (Million USD) and Growth Rate (2011-2021)
Figure Global Bevacizumab Biosimilar Revenue (Million UDS) and Growth Rate (2011-2021)
Table Global Bevacizumab Biosimilar Production of Key Manufacturers (2015 and 2016)
Table Global Bevacizumab Biosimilar Production Share by Manufacturers (2015 and 2016)
Figure 2015 Bevacizumab Biosimilar Production Share by Manufacturers
Figure 2016 Bevacizumab Biosimilar Production Share by Manufacturers
Table Global Bevacizumab Biosimilar Revenue (Million USD) by Manufacturers (2015 and 2016)
Table Global Bevacizumab Biosimilar Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Bevacizumab Biosimilar Revenue Share by Manufacturers
Table 2016 Global Bevacizumab Biosimilar Revenue Share by Manufacturers
Table Global Market Bevacizumab Biosimilar Average Price of Key Manufacturers (2015 and 2016)
Figure Global Market Bevacizumab Biosimilar Average Price of Key Manufacturers in 2015
Table Manufacturers Bevacizumab Biosimilar Manufacturing Base Distribution and Sales Area
Table Manufacturers Bevacizumab Biosimilar Product Type
Figure Bevacizumab Biosimilar Market Share of Top 3 Manufacturers
Figure Bevacizumab Biosimilar Market Share of Top 5 Manufacturers
Table Global Bevacizumab Biosimilar Production by Regions (2011-2016)
Figure Global Bevacizumab Biosimilar Production and Market Share by Regions (2011-2016)
Figure Global Bevacizumab Biosimilar Production Market Share by Regions (2011-2016)
Figure 2015 Global Bevacizumab Biosimilar Production Market Share by Regions
Table Global Bevacizumab Biosimilar Revenue by Regions (2011-2016)
Table Global Bevacizumab Biosimilar Revenue Market Share by Regions (2011-2016)
Table 2015 Global Bevacizumab Biosimilar Revenue Market Share by Regions
Table Global Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table North America Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table Europe Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table China Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table Japan Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table Southeast Asia Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table India Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Table Global Bevacizumab Biosimilar Consumption Market by Regions (2011-2016)
Table Global Bevacizumab Biosimilar Consumption Market Share by Regions (2011-2016)
Figure Global Bevacizumab Biosimilar Consumption Market Share by Regions (2011-2016)
Figure 2015 Global Bevacizumab Biosimilar Consumption Market Share by Regions
Table North America Bevacizumab Biosimilar Production, Consumption, Import & Export (2011-2016)
Table Europe Bevacizumab Biosimilar Production, Consumption, Import & Export (2011-2016)
Table China Bevacizumab Biosimilar Production, Consumption, Import & Export (2011-2016)
Table Japan Bevacizumab Biosimilar Production, Consumption, Import & Export (2011-2016)
Table Southeast Asia Bevacizumab Biosimilar Production, Consumption, Import & Export (2011-2016)
Table India Bevacizumab Biosimilar Production, Consumption, Import & Export (2011-2016)
Table Global Bevacizumab Biosimilar Production by Type (2011-2016)
Table Global Bevacizumab Biosimilar Production Share by Type (2011-2016)
Figure Production Market Share of Bevacizumab Biosimilar by Type (2011-2016)
Figure 2015 Production Market Share of Bevacizumab Biosimilar by Type
Table Global Bevacizumab Biosimilar Revenue by Type (2011-2016)
Table Global Bevacizumab Biosimilar Revenue Share by Type (2011-2016)
Figure Production Revenue Share of Bevacizumab Biosimilar by Type (2011-2016)
Figure 2015 Revenue Market Share of Bevacizumab Biosimilar by Type
Table Global Bevacizumab Biosimilar Price by Type (2011-2016)
Figure Global Bevacizumab Biosimilar Production Growth by Type (2011-2016)
Table Global Bevacizumab Biosimilar Consumption by Application (2011-2016)
Table Global Bevacizumab Biosimilar Consumption Market Share by Application (2011-2016)
Figure Global Bevacizumab Biosimilar Consumption Market Share by Application in 2015
Table Global Bevacizumab Biosimilar Consumption Growth Rate by Application (2011-2016)
Figure Global Bevacizumab Biosimilar Consumption Growth Rate by Application (2011-2016)
Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Pfizer Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer Bevacizumab Biosimilar Market Share (2011-2016)
Table Allergan Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Allergan Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Allergan Bevacizumab Biosimilar Market Share (2011-2016)
Table Alnylam Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Alnylam Pharmaceuticals Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Alnylam Pharmaceuticals Bevacizumab Biosimilar Market Share (2011-2016)
Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Amgen Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Bevacizumab Biosimilar Market Share (2011-2016)
Table Angstrom Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Angstrom Pharmaceuticals Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Angstrom Pharmaceuticals Bevacizumab Biosimilar Market Share (2011-2016)
Table Acceleron Pharma Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Acceleron Pharma Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Acceleron Pharma Bevacizumab Biosimilar Market Share (2011-2016)
Table Biocon Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Biocon Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Biocon Bevacizumab Biosimilar Market Share (2011-2016)
Table Bionomics Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Bionomics Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Bionomics Bevacizumab Biosimilar Market Share (2011-2016)
Table CASI Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table CASI Pharmaceuticals Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure CASI Pharmaceuticals Bevacizumab Biosimilar Market Share (2011-2016)
Table Celgene Corporation Basic Information, Manufacturing Base, Sales Area and Its Competitors
Table Celgene Corporation Bevacizumab Biosimilar Production, Revenue, Price and Gross Margin (2011-2016)
Figure Celgene Corporation Bevacizumab Biosimilar Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Bevacizumab Biosimilar
Figure Manufacturing Process Analysis of Bevacizumab Biosimilar
Figure Bevacizumab Biosimilar Industrial Chain Analysis
Table Raw Materials Sources of Bevacizumab Biosimilar Major Manufacturers in 2015
Table Major Buyers of Bevacizumab Biosimilar
Table Distributors/Traders List
Figure Global Bevacizumab Biosimilar Production and Growth Rate Forecast (2016-2021)
Figure Global Bevacizumab Biosimilar Revenue and Growth Rate Forecast (2016-2021)
Table Global Bevacizumab Biosimilar Production Forecast by Regions (2016-2021)
Table Global Bevacizumab Biosimilar Consumption Forecast by Regions (2016-2021)
Table Global Bevacizumab Biosimilar Production Forecast by Type (2016-2021)
Table Global Bevacizumab Biosimilar Consumption Forecast by Application (2016-2021)